Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G for DIANTHUS THERAPEUTICS INC Common Stock (DNTH).
- Disclosed ownership: 5.1%.
- Date of event: 31 Mar 2026.
BlackRock, Inc. - 31 Mar 2026 SCHEDULE 13G Report for DIANTHUS THERAPEUTICS INC Common Stock (DNTH)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- DNTH
- Shares outstanding
- 51,647,137 shares
- Disclosed Ownership
- 2,634,004 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Apr 2026, 16:12:24 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 24 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 5.1% ownership in DIANTHUS THERAPEUTICS INC Common Stock (DNTH) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 24 Apr 2025.
- Current filing was accepted on 27 Apr 2026, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5.1% | 2,634,004 | 2,582,959 | 0 | Spencer Fleming | Managing Director |